journal article·2015-11Open access

Robust Prediction of Personalized Cell Recognition from a Cancer Population by a Dual Targeting Nanoparticle Library

Tu C. Le, Bing Yan, David A. Winkler

Advanced Functional Materials· Volume 25· Issue 44

Abstract

Nanomaterials are used increasingly in diagnostics and therapeutics, particularly for malignancies. Efficient targeting of nanoparticles to specific cells is an important requirement for the development of successful nanoparticle‐based theranostics and personalized medicines. Gold nanoparticles are surface modified using a library of small organic molecules, and optionally folate, to investigate their ability to target four cell lines from common cancers, three having high levels of folate receptors expression. Uptake of these nanoparticles varies widely with surface chemistriy and cell lines. Sparse machine learning methods are used to computationally model surface chemistry–uptake relationships, to make quantitative predictions of uptake for new nanoparticle surface chemistries, and to elucidate molecular aspects of the interactions. The combination of combinatorial surface chemistry modification and machine learning models will facilitate the rapid development of targeted theranostics.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Computational Drug Discovery Methods · Machine Learning in Materials Science · Advanced Biosensing Techniques and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

CSIRO Manufacturing Clayton 3169 Australia

School of Chemistry and Chemical Engineering Shandong University Jinan 250100 China

Monash Institute of Pharmaceutical Sciences Parkville 3052 Australia

Latrobe Institute for Molecular Science Bundoora 3083 Australia

School of Chemical and Physical Sciences Flinders University Bedford Park 5042 Australia

References (25)

Show source-provided references
1. 10.1002/jps.2045710.1002/jps.20457 ↗
2. 10.1126/science.115516410.1126/science.1155164 ↗
3. Ran S. · Cancer Res. · 2002 · 62 · 6132
4. 10.1039/c1cc13284a10.1039/c1cc13284a ↗
5. 10.1073/pnas.141449911110.1073/pnas.1414499111 ↗
6. 10.1002/cmdc.20140006810.1002/cmdc.201400068 ↗
7. 10.1021/nl303144k10.1021/nl303144k ↗
8. 10.1038/nbt115910.1038/nbt1159 ↗
9. 10.1080/1062936X.2013.87436710.1080/1062936X.2013.874367 ↗
10. 10.1021/nl073015510.1021/nl0730155 ↗
11. Oh N. · Int. J. Nanomed. · 2014 · 9 · 51
12. 10.1007/s12274-014-0618-510.1007/s12274-014-0618-5 ↗
13. 10.1021/ja108527y10.1021/ja108527y ↗
14. 10.1016/j.jmgm.2014.10.00610.1016/j.jmgm.2014.10.006 ↗
15. 10.1016/B978-044452701-1.00007-710.1016/B978-044452701-1.00007-7 ↗
16. 10.1021/ci950164c10.1021/ci950164c ↗
17. 10.1016/j.ab.2004.12.02610.1016/j.ab.2004.12.026 ↗
18. 10.1016/j.bios.2015.06.01210.1016/j.bios.2015.06.012 ↗
19. 10.1016/j.surg.2013.06.04510.1016/j.surg.2013.06.045 ↗
20. Mauri A. · MATCH Commun. Math. Comput. Chem. · 2006 · 56 · 237
21. 10.1002/qsar.20081017310.1002/qsar.200810173 ↗
22. 10.1021/jm049621j10.1021/jm049621j ↗
23. 10.1021/jm980697n10.1021/jm980697n ↗
24. 10.1080/0892702000802237410.1080/08927020008022374 ↗
25. 10.1021/acs.jcim.5b0020610.1021/acs.jcim.5b00206 ↗